Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials.
Chang-Jiang DengJu YanYing-Ying ZhengTing-Ting WuYing PanXian-Geng HouSi-Fan WangSubinur SirajidinMikereyi AimaitijiangPublished in: BMJ open (2023)
CRD42018099600.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- st segment elevation myocardial infarction
- acute coronary syndrome
- coronary artery disease
- randomized controlled trial
- acute myocardial infarction
- cardiovascular events
- st elevation myocardial infarction
- systematic review
- antiplatelet therapy
- coronary artery bypass grafting
- risk factors
- atrial fibrillation
- stem cells
- emergency department
- adverse drug
- coronary artery bypass
- cardiovascular disease
- adipose tissue
- left ventricular
- cell therapy
- replacement therapy